We found a glycoside in sera of schizophrenic patients. This glycoside incr
eased climbing of mouse forced swimming and the climbing was decreased by d
opamine DI receptor antagonist SCH-23390 with a dose dependent manner. This
glycoside had much reactivity of GalNAc alpha1-3GalNAc, but not that of po
lymannoses nor that of Gal beta1-3GlcNAc alpha1-serine or threonine. This s
trongly suggests that the glycoside is an isolated O-glycoside, but not N-g
lycoside nor O-glycoside having core 1 or 2. The present findings suggest t
hat schizophrenic patients have the special glycoside affecting the D1 rece
ptor activity in their serum.